All news articles for February 2012

CRN welcomes FDA ‘wake-up’ call for GMP compliance

By Stephen Daniells

Many dietary supplement companies are not fully compliant with GMP regulations, putting them at risk of warning letters and more, but resources are available to help companies prepare for an FDA inspection, says the Council for Responsible Nutrition (CRN).

US Patent Office to re-examine second Neptune patent

US Patent Office to re-examine second Neptune patent

By Elaine Watson

The US Patent and Trademark Office (USPTO) has granted a request from Aker BioMarine to re-examine another US patent recently awarded to its arch rival Neptune Technologies & Bioressources.

Jack3D: Small study shows safety when used at recommended levels

Jack3D is safe: Study

By Shane Starling

A study of 25 healthy men has found DMAA-containing, pre-workout sports supplement, Jack3D, does not change resting heart rate, blood pressure or affect liver and kidney function when used at recommended dosage levels.

Vitamin D3 may cut fat mass, boost heart health markers

Vitamin D3 may cut fat mass, boost heart health markers

By Stephen Daniells

Daily supplements of vitamin D3 may improve certain markers of heart health like HDL cholesterol, and lead to significant reductions in body fat mass in overweight and obese people, says a new study.

UK begins DMAA crackdown

UK begins DMAA crackdown

By Shane Starling

DMAA-containing Jack3D and products like it are unauthorised drugs and being stripped from UK retail shelves and online catalogues as part of a crackdown against sports supplements by the medicines regulator, the MHRA.

Beta-alanine is the rate-limiting precursor of carnosine, which is claimed to decrease fatigue in athletes.

DNP hits back at NAI in beta-alanine patent infringement row

By Elaine Watson

DNP International – the latest in a string of firms to be sued by Natural Alternatives International (NAI) for patent infringement over beta-alanine - insists the patent at issue is invalid and predicts it will “ultimately be vindicated” by the courts.

GNC: 'There is also no scientific/medical evidence that demonstrates any causal link between DMAA and any adverse medical condition, let alone a death'

GNC, Cellucor and Woodbolt targeted in new DMAA lawsuit

By Elaine Watson

GNC, Cellucor Sports Nutrition and others have been accused of misleading consumers over the source, regulatory status and safety of the controversial stimulant DMAA (1,3 Dimethylamylamine) in a new class action lawsuit filed in California.

Picture: Steven Foster, Scutellaria lateriflora, 2012

ABC: Why is skullcap still being adulterated with germander?

By Elaine Watson

Germander is still being used as a substitute for skullcap in dietary supplements, despite ongoing attempts to raise awareness about the problem, according to a new paper published by the American Botanical Council (ABC).

GNC: DMAA saga has had ‘no impact whatsoever’ on sales

GNC: DMAA saga has had ‘no impact whatsoever’ on sales

By Elaine Watson

The furor surrounding the safety and legal status of DMAA (1,3-Dimethylamylamine) - a stimulant used in several pre-workout supplements - has not dented sales at supplements giant GNC, bosses have revealed.

Follow us

Products

View more

Webinars